PT88930A - Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem

Info

Publication number
PT88930A
PT88930A PT88930A PT8893088A PT88930A PT 88930 A PT88930 A PT 88930A PT 88930 A PT88930 A PT 88930A PT 8893088 A PT8893088 A PT 8893088A PT 88930 A PT88930 A PT 88930A
Authority
PT
Portugal
Prior art keywords
nucleosides
preparation
pharmaceutical compositions
compositions containing
new analyses
Prior art date
Application number
PT88930A
Other languages
English (en)
Other versions
PT88930B (pt
Inventor
Karl Nils Gunnar Johansson
Bjoern Gunnar Lindborg
Ulf Norinder
Goeran Bertil Stening
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PT88930A publication Critical patent/PT88930A/pt
Publication of PT88930B publication Critical patent/PT88930B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT88930A 1987-11-03 1988-11-03 Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem PT88930B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704298A SE8704298D0 (sv) 1987-11-03 1987-11-03 Compounds for use in therapy

Publications (2)

Publication Number Publication Date
PT88930A true PT88930A (pt) 1988-12-01
PT88930B PT88930B (pt) 1993-01-29

Family

ID=20370102

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88930A PT88930B (pt) 1987-11-03 1988-11-03 Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem

Country Status (9)

Country Link
EP (1) EP0322384B1 (pt)
JP (1) JPH01151595A (pt)
AT (1) ATE135363T1 (pt)
AU (1) AU615681B2 (pt)
DE (1) DE3855099D1 (pt)
DK (1) DK602988A (pt)
HU (1) HU211132A9 (pt)
PT (1) PT88930B (pt)
SE (1) SE8704298D0 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US5506215A (en) * 1987-11-03 1996-04-09 Medivir Ab 1-(3'-fluoro-2',3'-dideoxy-β-D-ribofuranosyl)-5-substituted pyrimidine nucleosides
GB8726136D0 (en) * 1987-11-07 1987-12-09 Wellcome Found Therapeutic nucleosides
EP0346108A3 (en) * 1988-06-09 1991-04-24 The Wellcome Foundation Limited Anti-infective nucleosides
US5157114A (en) * 1988-08-19 1992-10-20 Burroughs Wellcome Co. 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
GB8823319D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
GR1000522B (el) * 1988-10-11 1992-08-25 Medivir Ab Μεθοδος παρασκευης νεων αναλογων νουκλεοζιτων.
DD293498A5 (de) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier
FR2654106B1 (fr) * 1989-11-03 1992-01-10 Synthelabo Derives phosphores de cytosine, leur preparation et leur application en therapeutique.
WO1991006554A1 (en) * 1989-11-06 1991-05-16 Nycomed As Nucleoside derivatives
GB9012899D0 (en) * 1990-06-09 1990-08-01 Wellcome Found Anti-hbv pyrimidine nucleoside
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
DE4110977A1 (de) * 1991-04-05 1992-10-08 Bayer Ag Substituierte 2',3'-didesoxy-5-trifluormethyluridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9125271D0 (en) * 1991-11-27 1992-01-29 Wellcome Found Anti-hbv pyrimidine nucleoside
FR2684997A1 (fr) * 1991-12-12 1993-06-18 Centre Nat Rech Scient Derives de la 9-(beta-d-xylofurannosyl) adenine et de la 1-(beta-d-xylofurannosyl) cytosine, leur preparation et leur application en therapeutique.
DE4207363A1 (de) * 1992-03-04 1993-09-09 Max Delbrueck Centrum Antivirale nucleosidanaloga, ihre herstellung und ihre pharmazeutische verwendung
FR2691463A1 (fr) * 1992-05-25 1993-11-26 Centre Nat Rech Scient Dérivés nucléotidiques, leur préparation et leur application en thérapeutique.
FR2692265B1 (fr) * 1992-05-25 1996-11-08 Centre Nat Rech Scient Composes biologiquement actifs de type phosphotriesters.
US5770725A (en) * 1992-05-25 1998-06-23 Gosselin; Gilles Phosphotriester type biologically active compounds
US5849905A (en) * 1994-11-23 1998-12-15 Centre National De La Recherche Scientifique Biologically active phosphotriester-type nucleosides and methods for preparing same
US6020482A (en) * 1992-05-25 2000-02-01 Gosselin; Gilles Phosphotriester type biologically active compounds
CA2159628A1 (en) * 1993-03-31 1994-10-13 Prasad Venkata Chala Chaturvedula Bifunctional nucleosides, oligomers thereof, and methods of making and using the same
US5955591A (en) * 1993-05-12 1999-09-21 Imbach; Jean-Louis Phosphotriester oligonucleotides, amidites and method of preparation
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
WO1995007086A1 (en) * 1993-09-10 1995-03-16 Emory University Nucleosides with anti-hepatitis b virus activity
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
EP0788507B1 (en) * 1994-10-24 2004-12-15 Genencor International, Inc. L-pyranosyl nucleosides
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
JP2008110983A (ja) * 1999-05-12 2008-05-15 Yamasa Shoyu Co Ltd ４’−ｃ−エチニルヌクレオシド化合物
JP2003523978A (ja) 2000-02-18 2003-08-12 シャイアー・バイオケム・インコーポレイテッド ヌクレオシドアナログを用いるｆｌａｖｉｖｉｒｕｓ感染の処置もしくは予防するための方法
US7244717B2 (en) 2001-08-24 2007-07-17 Koronis Pharmaceuticals, Incorporated Mutagenic nucleoside analogs for the treatment of viral disease
CN104072558B (zh) * 2013-03-26 2016-09-28 河南师范大学 具有抗hiv活性的5-取代嘧啶核苷-四氢噻唑杂化体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282921A (en) * 1964-06-04 1966-11-01 Syntex Corp Halo-deoxynucleosides and processes for the preparation thereof
US3687931A (en) * 1970-03-19 1972-08-29 Syntex Corp Halogenated purine and pyrimidine nucleosides and process therefor
DE3045375A1 (de) * 1980-12-02 1982-07-01 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Neue substituierte pyrimidin-nukleoside mit antiviraler wirkung, verfahren zu deren herstellung und daraus zubereitete arzneiformen
GB2181128A (en) * 1985-09-17 1987-04-15 Wellcome Found 3'-azidonucleosides
DD279407A1 (de) * 1986-07-24 1990-06-06 Akad Wissenschaften Ddr Verfahren zur herstellung eines mittels gegen aids

Also Published As

Publication number Publication date
SE8704298D0 (sv) 1987-11-03
JPH01151595A (ja) 1989-06-14
DK602988D0 (da) 1988-10-28
DE3855099D1 (de) 1996-04-18
EP0322384A1 (en) 1989-06-28
HU211132A9 (en) 1995-10-30
EP0322384B1 (en) 1996-03-13
DK602988A (da) 1989-05-04
PT88930B (pt) 1993-01-29
AU615681B2 (en) 1991-10-10
AU2452288A (en) 1989-05-04
ATE135363T1 (de) 1996-03-15

Similar Documents

Publication Publication Date Title
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
PT82580B (pt) Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
PT82610B (pt) Processo para a preparacao de tiazolidino-dionas hipoglicemicas
PT95510A (pt) Processo de preparacao de pirimidina 4'-tionucleosidos e de composicoes farmaceuticas que os contem
EE02995B1 (et) 1,3-oksatiolaannukleosiidi analoogide kasutamine hepatiit B ravimpreparaatide valmistamiseks
BR0108600A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, métodos para tratamento de uma doença mediada por quimiocina e para tratamento de uma doença inflamatória
PT89502A (pt) Processo para a preparacao de derivados de 2-(2-hidroxi-3-fenoxi-metilo e de composicoes farmaceuticas que os contem
PT92949A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da cisteina para o tratamento de doencas associadas com infeccoes provocadas por virus da imunodeficiencia humano
NL960024I1 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus gesmette patiënten.
ATE99953T1 (de) Antivirales kombinationspraeparat.
PT97749A (pt) Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral
ES2052533T3 (es) Composicion farmaceutica que comprende 2',3'-didesoxicitidin-2'-eno (2',3'-dideshidrocitidina) para tratar pacientes infectados con retrovirus.
DK462688A (da) Anvendelse af nukleosider til fremstilling af laegemiddel til behandling af sygdomme foraarsaget af retrovirus eller hepatitis b virus
BR9306207A (pt) Composiçao farmacéutica e processo para o tratamento de infecçao ou doença causada pelo vírus da hepatite b processo para a preparaçao da composiçao e uso de fiau ou de uma pró-droga ou metabolito do mesmo
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
FR2536751B1 (fr) Nouveaux derives de tricyclophosphazenes, procede pour leur preparation et leur application en tant que medicament
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
DK707988D0 (da) Fremgangsmaade til at haemme virus
MC1930A1 (fr) Produit antiviral
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
PT90169A (pt) Processo para a preparacao de composicoes farmaceuticas contendo timopentina para o tratamento de pacientes sofrendo de viremias provocadas por hiv
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
WO1988007367A3 (en) Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs
PT89500A (pt) Processo para a preparacao de derivados de tetra-hidropiridina e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920729

PC3A Transfer or assignment

Free format text: 921223 MEDIVIR AB SE

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970131